UA73523C2 - Спосіб приготування сферичних агломератів телітроміцину та їх застосування для приготування лікарських форм - Google Patents
Спосіб приготування сферичних агломератів телітроміцину та їх застосування для приготування лікарських форм Download PDFInfo
- Publication number
- UA73523C2 UA73523C2 UA2002032354A UA2002032354A UA73523C2 UA 73523 C2 UA73523 C2 UA 73523C2 UA 2002032354 A UA2002032354 A UA 2002032354A UA 2002032354 A UA2002032354 A UA 2002032354A UA 73523 C2 UA73523 C2 UA 73523C2
- Authority
- UA
- Ukraine
- Prior art keywords
- telithromycin
- preparation
- spherical agglomerates
- differs
- crystallization
- Prior art date
Links
- LJVAJPDWBABPEJ-PNUFFHFMSA-N telithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]([C@]2(OC(=O)N(CCCCN3C=C(N=C3)C=3C=NC=CC=3)[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)OC)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O LJVAJPDWBABPEJ-PNUFFHFMSA-N 0.000 title claims abstract description 21
- 229960003250 telithromycin Drugs 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 5
- 239000000725 suspension Substances 0.000 claims abstract description 7
- 239000013078 crystal Substances 0.000 claims abstract description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- 238000002425 crystallisation Methods 0.000 claims description 7
- 230000008025 crystallization Effects 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 6
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- XCAUINMIESBTBL-UHFFFAOYSA-N lead(ii) sulfide Chemical group [Pb]=S XCAUINMIESBTBL-UHFFFAOYSA-N 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000012876 topography Methods 0.000 claims 1
- 239000003094 microcapsule Substances 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000002245 particle Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000005354 coacervation Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- -1 4-(4-(3-pyridyl)-1H-imidazol-1-yl)butyl Chemical group 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 238000001033 granulometry Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9910810A FR2797875B1 (fr) | 1999-08-26 | 1999-08-26 | Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques |
| PCT/FR2000/002393 WO2001014393A2 (fr) | 1999-08-26 | 2000-08-28 | Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA73523C2 true UA73523C2 (uk) | 2005-08-15 |
Family
ID=9549351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002032354A UA73523C2 (uk) | 1999-08-26 | 2000-08-28 | Спосіб приготування сферичних агломератів телітроміцину та їх застосування для приготування лікарських форм |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US6825218B1 (he) |
| EP (1) | EP1212336B1 (he) |
| JP (1) | JP4871467B2 (he) |
| KR (1) | KR100718222B1 (he) |
| CN (1) | CN1183151C (he) |
| AR (1) | AR025398A1 (he) |
| AT (1) | ATE255590T1 (he) |
| AU (1) | AU774385B2 (he) |
| BR (1) | BR0013569B1 (he) |
| CA (1) | CA2382497C (he) |
| CO (1) | CO5190666A1 (he) |
| CZ (1) | CZ2002594A3 (he) |
| DE (1) | DE60006976T2 (he) |
| DK (1) | DK1212336T3 (he) |
| EA (1) | EA005080B1 (he) |
| ES (1) | ES2209970T3 (he) |
| FR (1) | FR2797875B1 (he) |
| HK (1) | HK1049167B (he) |
| HR (1) | HRP20020167B1 (he) |
| HU (1) | HU229075B1 (he) |
| IL (2) | IL148128A0 (he) |
| ME (2) | MEP20108A (he) |
| MX (1) | MXPA02001988A (he) |
| NO (1) | NO322622B1 (he) |
| PL (1) | PL204100B1 (he) |
| PT (1) | PT1212336E (he) |
| RS (1) | RS50433B (he) |
| SI (1) | SI1212336T1 (he) |
| SK (1) | SK287588B6 (he) |
| TR (1) | TR200200506T2 (he) |
| TW (1) | TWI272949B (he) |
| UA (1) | UA73523C2 (he) |
| WO (1) | WO2001014393A2 (he) |
| ZA (1) | ZA200201599B (he) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9902202D0 (sv) * | 1999-06-10 | 1999-06-10 | Astra Ab | Production of aggregates |
| FR2821747B1 (fr) * | 2001-03-09 | 2004-07-02 | Ethypharm Lab Prod Ethiques | Suspension de telithromycine a gout masque |
| MXPA05000322A (es) * | 2002-07-19 | 2005-03-31 | Aventis Pharma Sa | Composicion oral de telitromicina con sabor enmascarado. |
| WO2004009059A1 (en) * | 2002-07-19 | 2004-01-29 | Aventis Pharma S.A. | Taste masked oral composition of telithromycin |
| US20040013737A1 (en) * | 2002-07-19 | 2004-01-22 | Philippe Becourt | Taste masked oral composition of telithromycin |
| WO2004073827A1 (en) * | 2003-02-21 | 2004-09-02 | The University Of Bath | Process for the production of particles |
| US20050014706A1 (en) * | 2003-07-14 | 2005-01-20 | Kanakeshwari Falzari | Method of treating tuberculosis |
| WO2007039914A2 (en) * | 2005-10-06 | 2007-04-12 | Alembic Limited | Novel polymorphs of telithromycin |
| US20090075917A1 (en) * | 2007-09-19 | 2009-03-19 | Protia, Llc | Deuterium-enriched telithromycin |
| KR101324862B1 (ko) * | 2011-07-12 | 2013-11-01 | (주)에이에스텍 | 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3468336D1 (en) * | 1983-06-22 | 1988-02-11 | Univ Ohio State Res Found | Small particle formation |
| JPH02227130A (ja) * | 1989-02-28 | 1990-09-10 | Taisho Pharmaceut Co Ltd | 球形微小凍結粒子の製造法 |
| FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
-
1999
- 1999-08-26 FR FR9910810A patent/FR2797875B1/fr not_active Expired - Fee Related
-
2000
- 2000-08-02 TW TW089115526A patent/TWI272949B/zh not_active IP Right Cessation
- 2000-08-18 CO CO00062195A patent/CO5190666A1/es active IP Right Grant
- 2000-08-25 AR ARP000104426A patent/AR025398A1/es unknown
- 2000-08-28 PL PL353137A patent/PL204100B1/pl unknown
- 2000-08-28 IL IL14812800A patent/IL148128A0/xx active IP Right Grant
- 2000-08-28 ME MEP-201/08A patent/MEP20108A/xx unknown
- 2000-08-28 CZ CZ2002594A patent/CZ2002594A3/cs unknown
- 2000-08-28 UA UA2002032354A patent/UA73523C2/uk unknown
- 2000-08-28 DE DE60006976T patent/DE60006976T2/de not_active Expired - Lifetime
- 2000-08-28 HU HU0202842A patent/HU229075B1/hu not_active IP Right Cessation
- 2000-08-28 DK DK00958756T patent/DK1212336T3/da active
- 2000-08-28 CA CA2382497A patent/CA2382497C/fr not_active Expired - Fee Related
- 2000-08-28 JP JP2001518723A patent/JP4871467B2/ja not_active Expired - Fee Related
- 2000-08-28 US US10/049,874 patent/US6825218B1/en not_active Expired - Fee Related
- 2000-08-28 ES ES00958756T patent/ES2209970T3/es not_active Expired - Lifetime
- 2000-08-28 MX MXPA02001988A patent/MXPA02001988A/es active IP Right Grant
- 2000-08-28 PT PT00958756T patent/PT1212336E/pt unknown
- 2000-08-28 BR BRPI0013569-0A patent/BR0013569B1/pt not_active IP Right Cessation
- 2000-08-28 AU AU70181/00A patent/AU774385B2/en not_active Ceased
- 2000-08-28 TR TR2002/00506T patent/TR200200506T2/xx unknown
- 2000-08-28 KR KR1020027002404A patent/KR100718222B1/ko not_active IP Right Cessation
- 2000-08-28 RS YUP-132/02A patent/RS50433B/sr unknown
- 2000-08-28 WO PCT/FR2000/002393 patent/WO2001014393A2/fr active IP Right Grant
- 2000-08-28 SI SI200030287T patent/SI1212336T1/xx unknown
- 2000-08-28 SK SK253-2002A patent/SK287588B6/sk not_active IP Right Cessation
- 2000-08-28 EP EP00958756A patent/EP1212336B1/fr not_active Expired - Lifetime
- 2000-08-28 ME MEP-2008-201A patent/ME00112B/me unknown
- 2000-08-28 AT AT00958756T patent/ATE255590T1/de active
- 2000-08-28 EA EA200200294A patent/EA005080B1/ru not_active IP Right Cessation
- 2000-08-28 CN CNB008120943A patent/CN1183151C/zh not_active Expired - Fee Related
-
2002
- 2002-02-12 IL IL148128A patent/IL148128A/he not_active IP Right Cessation
- 2002-02-25 HR HR20020167A patent/HRP20020167B1/xx not_active IP Right Cessation
- 2002-02-26 NO NO20020926A patent/NO322622B1/no not_active IP Right Cessation
- 2002-02-26 ZA ZA200201599A patent/ZA200201599B/en unknown
-
2003
- 2003-02-21 HK HK03101349.3A patent/HK1049167B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100209175B1 (ko) | 수중에서 신속하게 현탁되는 약제학적 조성물 | |
| KR900000212B1 (ko) | 즉석 균질마이크로 캅셀 현탁액의 제조방법 | |
| JP4129995B2 (ja) | 水性媒体に迅速に懸濁する医薬組成物 | |
| KR880001752B1 (ko) | 약제 혼합물용 건조 분말의 제조 방법 | |
| KR100358211B1 (ko) | 발포시스템및제약활성물질을함유하는과립제품이나정제와그제조방법 | |
| ES2253403T5 (es) | Formulacion de entecavir de dosis baja y su uso. | |
| UA73302C2 (en) | Oral dosage form of omeprazole without enteric coating | |
| JPH0288520A (ja) | ミクロ−粒子及び／又はナノ−粒子から成る新規固体状の多孔性、単位投与製剤、及びその製造方法 | |
| HU229044B1 (hu) | Fenofibrátot tartalmazó gyógyszerkészítmények és eljárás elõállításukra | |
| UA73523C2 (uk) | Спосіб приготування сферичних агломератів телітроміцину та їх застосування для приготування лікарських форм | |
| JPH0573727B2 (he) | ||
| HUE027664T2 (en) | Nalbuphine-based preparations and their use | |
| UA73529C2 (uk) | Гранульована композиція кветіапіну (варіанти), спосіб її приготування, спосіб лікування захворювань центральної нервової системи та набір, що містить таку композицію | |
| JP2010524926A (ja) | ウルソデオキシコール酸の高用量組成物 | |
| ZA200103630B (en) | Particles coated with granulated crystalline ibuprofen. | |
| JPH11510191A (ja) | ５―ａｓａを含有する修飾放出性経口医薬組成物および腸疾患の治療方法 | |
| US4832955A (en) | Controlled release potassium chloride composition | |
| UA75656C2 (en) | Crystalline co-precipitate of gatifloxacin and fatty acid utilized for pediatric formulations (variants) and method for its manufacture | |
| UA82532C2 (uk) | Спосіб виготовлення капсул флуконазолу з покращеним вивільненням | |
| CN101003536A (zh) | 恩替卡韦盐及其制备 | |
| HU221435B (en) | Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production | |
| AU2002244857B2 (en) | Pharmaceutical product with reticulated crystalline microstructure | |
| AU2002244857A1 (en) | Pharmaceutical product with reticulated crystalline microstructure | |
| BR112018069973A2 (pt) | uma composição farmacêutica compreendendo racecadotrila e processo para a preparação da mesma |